Completed NCT02192554
This study is completed in the United States, in France, in Canada, .... It focuses on Mental health.
In Canada Mental health Other
Countries United States, France, Canada, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Mental health Completed NCT01396447
This study is completed in the United States, in Canada, in Bulgaria, .... It is testing safety, Tolerability, and Efficacy of Cariprazine in Participants With Depression for depression in bipolarity.
In Canada Bipolarity, Depression Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States, Canada, Bulgaria, ...
Sponsor Forest Laboratories
Condition Bipolarity, Depression Completed NCT04153864
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Depression Behavioral Over 18 Years
Countries United States, Canada
Sponsor Mount Sinai Hospital, Canada
Condition Depression Completed NCT06781788
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Anxiety Behavioral Over 8 Years
Countries Canada
Sponsor Université du Québec a Montréal
Condition Anxiety Completed NCT07619768
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Anxiety Behavioral Over 18 Years
Countries Canada
Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Condition Anxiety Completed NCT04466345
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Depression Biological From 18 Years to 60 Years
Countries Canada
Sponsor University Health Network, Toronto
Condition Depression Active Not Recruiting NCT05333003
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Schizophrenia Drug From 18 Years to 70 Years
Countries Canada
Sponsor Centre for Addiction and Mental Health
Condition Schizophrenia Active Not Recruiting NCT06433635
This study is active but not recruiting in the United States and in Canada. It is testing sequential Multiple Assignment Randomized Trial for depression in bipolarity.
In Canada Bipolarity, Depression Drug From 18 Years to 75 Years
Countries United States, Canada
Sponsor Massachusetts General Hospital
Condition Bipolarity, Depression Completed NCT00206141
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Bipolarity, Depression Drug From 18 Years to 65 Years
Countries Canada, Croatia, Estonia, ...
Sponsor AstraZeneca
Condition Bipolarity, Depression Completed NCT00328978
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Schizophrenia Drug From 18 Years to 65 Years
Countries Canada
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT00234377
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Schizophrenia Drug From 18 Years to 65 Years
Countries Canada, Finland, Germany, ...
Sponsor AstraZeneca
Condition Schizophrenia Terminated NCT00182533
This summary needs review. Please check the official study record and contact the research team for details.
In Canada Anxiety, Depression, ... Drug From 18 Years to 70 Years
Countries Canada
Sponsor Hamilton Health Sciences Corporation
Condition Anxiety, Depression, ...